Antidepressants for the acute treatment of bipolar depression: A systematic review and meta-analysis

Journal of Clinical Psychiatry

Volumn 72, Issue 2, 2011, Pages 156-167

  Sidor, Michelle M ^a   MacQueen, Glenda M ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CITALOPRAM; DESIPRAMINE; FLUOXETINE; FLUOXETINE PLUS OLANZAPINE; IDAZOXAN; IMIPRAMINE; LAMOTRIGINE; LITHIUM; MOCLOBEMIDE; PAROXETINE; PLACEBO; SERTRALINE; VALPROATE SEMISODIUM; VALPROIC ACID; VENLAFAXINE;

BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BIPOLAR MANIA; COCHRANE LIBRARY; CYCLOTHYMIA; DISEASE REGISTRY; DRUG EFFICACY; DRUG SAFETY; EMBASE; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MEDLINE; META ANALYSIS; MIXED MANIA AND DEPRESSION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 79951977965     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09r05385gre     Document Type: Review

References (58)

1. Ketter TA, Calabrese JR. Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature. J Clin Psychiatry. 2002;63(2):146-151.
2. Judd LL, Akiskal HS. Depressive episodes and symptoms dominate the longitudinal course of bipolar disorder. Curr Psychiatry Rep. 2003;5(6): 417-418. doi:10.107/s1920-03-07-2 PubMed (Pubitemid 38899236)
3. Judd LL, Akiskal HS, Schettler PJ, et al. Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch Gen Psychiatry. 2005;62(12):1322-1330. doi:10.101/archpsyc.62.12.132 PubMed (Pubitemid 41746610)
4. Dilsaver SC, Chen YW, Swann AC, et al. Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania. Psychiatry Res. 1997;73(1-2):47-56. doi:10.1016/S0165-1781(97)0109-1 PubMed (Pubitemid 28032207)
5. Altshuler LL, Post RM, Leverich GS, et al. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry. 1995; 152(8):1130-1138.
6. Boerlin HL, Gitlin MJ, Zoellner LA, et al. Bipolar depression and antidepressant- induced mania: a naturalistic study. J Clin Psychiatry. 1998;59(7):374-379.
7. Henry C, Sorbara F, Lacoste J, et al. Antidepressant-induced mania in bipolar patients: identification of risk factors. J Clin Psychiatry. 2001; 62(4):249-255.
8. Truman CJ, Goldberg JF, Ghaemi SN, et al. Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry. 2007;68(10):1472-1479. doi:10.408/JCP.v68n102 PubMed (Pubitemid 350073393)
9. Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry. 1994;164(4):549-550. doi:10.192/bjp.164.4.549 PubMed (Pubitemid 24141686)
10. Visser HM, Van Der Mast RC. Bipolar disorder, antidepressants and induction of hypomania or mania: a systematic review. World J Biol Psychiatry. 2005;6(4):231-241.
11. Lewis JL, Winokur G. The induction of mania: a natural history study with controls. Arch Gen Psychiatry. 1982;39(3):303-306.
12. Angst J. Switch from depression to mania-a record study over decades between 1920 and 1982. Psychopathology. 1985;18(2-3):140-154.
13. Quitkin FM, Kane J, Rifkin A, et al. Prophylactic lithium carbonate with and without imipramine for bipolar I patients: a double-blind study. Arch Gen Psychiatry. 1981;38(8):902-907.
14. Wehr TA, Goodwin FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry. 1979;36(5):555-559.
15. Wehr TA, Sack DA, Rosenthal NE, et al. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry. 1988;145(2):179-184.
16. Licht RW, Gijsman H, Nolen WA, et al. Are antidepressants safe in the treatment of bipolar depression? a critical evaluation of their potential risk to induce switch into mania or cycle acceleration. Acta Psychiatr Scand. 2008;118(5):337-346.
17. Yatham LN, Kennedy SH, O'Donovan C, et al. Canadian Network for Mood and Anxiety Treatments. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord. 2005; 7(suppl 3):5-69.
18. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002; 159(suppl 4):1-50.
19. Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry. 2009; 194(1):4-9.
20. Goodwin GM. Quetiapine more effective than placebo for depression in bipolar I and II disorder. Evid Based Ment Health. 2007;10(3):82.
21. Thase ME, Macfadden W, Weisler RH, et al. BOLDER II Study Group. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol. 2006;26(6):600-609. doi:10.1097/01.jcp.0248603.76231.b7 PubMed (Pubitemid 44772737)
22. Calabrese JR, Keck PE Jr, Macfadden W, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry. 2005;162(7):1351-1360. doi:10.176/api.ajp.162.7. 1351 PubMed (Pubitemid 40905587)
23. Baldessarini RJ, Leahy L, Arcona S, et al. Patterns of psychotropic drug prescription for US patients with diagnoses of bipolar disorders. Psychiatr Serv. 2007;58(1):85-91.
24. Goldberg JF, Brooks JO 3rd, Kurita K, et al. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. J Clin Psychiatry. 2009;70(2):155-162.
25. Gijsman HJ, Geddes JR, Rendell JM, et al. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry. 2004;161(9):1537-1547. doi:10.176/api.ajp.161.9.1537 PubMed (Pubitemid 39201448)
26. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2 (updated September 2009). www.cochrane-handbook. org. Accessed June 23, 2010.
27. Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapinefluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry. 2003;60(11):1079-1088. doi:10.101/archpsyc.60.1.1079 PubMed (Pubitemid 37429647)
28. Geretsegger C, Bitterlich W, Stelzig R, et al. Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients. Eur Neuropsychopharmacol. 2008;18(2):141-146. doi:10.1016/j. euroneuro.207.09.02 PubMed (Pubitemid 350296848)
29. Goldberg JF, Perlis RH, Ghaemi SN, et al. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry. 2007;164(9):1348-1355. doi:10.176/api.ajp.207.0512032 PubMed (Pubitemid 47461134)
30. Nierenberg AA, Ostacher MJ, Calabrese JR, et al. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry. 2006;163(2):210-216. doi:10.176/api.ajp.163.2.210 PubMed (Pubitemid 44480839)
31. Parker G, Tully L, Olley A, et al. SSRIs as mood stabilizers for Bipolar II Disorder? a proof of concept study. J Affect Disord. 2006;92(2-3):205-214.
32. Leverich GS, Altshuler LL, Frye MA, et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry. 2006;163(2):232-239. doi:10.176/api.ajp.163. 2.232 PubMed (Pubitemid 44480842)
33. Altshuler LL, Suppes T, Black DO, et al. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. Am J Psychiatry. 2006;163(2): 313-315. doi:10.176/api.ajp.163.2.313 PubMed (Pubitemid 44480853)
34. Keck PE Jr, Corya SA, Altshuler LL, et al. Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression. J Clin Psychiatry. 2005;66(5):611-616. doi:10.408/JCP.v6n051 PubMed (Pubitemid 40733704)
35. Agosti V, Stewart JW. Efficacy and safety of antidepressant monotherapy in the treatment of bipolar II depression. Int Clin Psychopharmacol. 2007; 22(5):309-311. doi:10.1097/YIC.0b013e3280c28410 PubMed (Pubitemid 47237550)
36. Himmelhoch JM, Fuchs CZ, Symons BJ. A double-blind study of tranylcypromine treatment of major anergic depression. J Nerv Ment Dis. 1982;170(10):628-634.
37. De Wilde JE, Doogan DP. Fluvoxamine and chlorimipramine in endogenous depression. J Affect Disord. 1982;4(3):249-259. doi:10.1016/0165-0327(82)909-X PubMed (Pubitemid 12053767)
38. Mendlewicz J, Youdim MB. Antidepressant potentiation of 5- hydroxytryptophan by L-deprenil in affective illness. J Affect Disord. 1980;2(2):137-146. doi:10.1016/0165-0327(80)9013-0 PubMed (Pubitemid 10117157)
39. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007;356(17):1711-1722. doi:10.1056/NEJMoa064135 PubMed (Pubitemid 46658703)
40. Amsterdam JD, Shults J. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression-lack of manic induction. J Affect Disord. 2005;87(1):121-130. doi:10.1016/j.jad.205.02.018 PubMed (Pubitemid 40828211)
41. Shelton RC, Stahl SM. Risperidone and paroxetine given singly and in combination for bipolar depression. J Clin Psychiatry. 2004;65(12): 1715-1719.
42. Nemeroff CB, Evans DL, Gyulai L, et al. Double-blind, placebocontrolled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry. 2001;158(6):906-912. doi:10.176/api.ajp.158.6.906 PubMed (Pubitemid 32547620)
43. Cohn JB, Collins G, Ashbrook E, et al. A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol. 1989;4(4):313-322.
44. Schaffer A, Zuker P, Levitt A. Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression. J Affect Disord. 2006;96(1-2):95-99. doi:10.1016/j.jad.206.05.023 PubMed (Pubitemid 44548053)
45. Bocchetta A, Bernardi F, Burrai C, et al. A double-blind study of L-sulpiride versus amitriptyline in lithium-maintained bipolar depressives. Acta Psychiatr Scand. 1993;88(6):434-439. doi:10.1/j.160-047.193.tb03487.x PubMed (Pubitemid 24001708)
46. Brown EB, McElroy SL, Keck PE Jr, et al. A 7-week, randomized, doubleblind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J Clin Psychiatry. 2006;67(7): 1025-1033. doi:10.408/JCP.v67n0703 PubMed (Pubitemid 44230872)
47. Grossman F, Potter WZ, Brown EA, et al. A double-blind study comparing idazoxan and bupropion in bipolar depressed patients. J Affect Disord. 1999;56(2-3):237-243. doi:10.1016/S0165-0327(9)041-5 PubMed (Pubitemid 30058228)
48. Young LT, Joffe RT, Robb JC, et al. Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry. 2000;157(1):124-126.
49. Post RM, Altshuler LL, Leverich GS, et al. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry. 2006;189(2):124-131. doi:10.192/bjp.bp.105.013045 PubMed (Pubitemid 44231270)
50. Sachs GS, Lafer B, Stoll AL, et al. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry. 1994;55(9): 391-393.
51. Silverstone T. Moclobemide vs imipramine in bipolar depression: a multicentre double-blind clinical trial. Acta Psychiatr Scand. 2001; 104(2):104-109. doi:10.1034/j.160-047.201.0240.x PubMed (Pubitemid 32656085)
52. Himmelhoch JM, Thase ME, Mallinger AG, et al. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry. 1991; 148(7):910-916.
53. Fogelson DL, Bystritsky A, Pasnau R. Bupropion in the treatment of bipolar disorders: the same old story? J Clin Psychiatry. 1992;53(12): 443-446.
54. Gao K, Kemp DE, Ganocy SJ, et al. Treatment-emergent mania/ hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder. Bipolar Disord. 2008;10(8):907-915.
55. McIntyre RS, Mancini DA, McCann S, et al. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disord. 2002; 4(3):207-213. doi:10.1034/j.139-5618.202.0189.x PubMed (Pubitemid 34591247)
56. Bond DJ, Noronha MM, Kauer-Sant'Anna M, et al. Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and metaanalysis. J Clin Psychiatry. 2008;69(10):1589-1601.
57. van der Loos ML, Mulder PG, Hartong EG, et al. LamLit Study Group. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. J Clin Psychiatry. 2009;70(2):223-231.
58. Ghaemi SN, Wingo AP, Filkowski MA, et al. Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr Scand. 2008;118(5):347-356.